These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 16204037)
1. Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function. Patel NS; Li JL; Generali D; Poulsom R; Cranston DW; Harris AL Cancer Res; 2005 Oct; 65(19):8690-7. PubMed ID: 16204037 [TBL] [Abstract][Full Text] [Related]
2. Up-regulation of endothelial delta-like 4 expression correlates with vessel maturation in bladder cancer. Patel NS; Dobbie MS; Rochester M; Steers G; Poulsom R; Le Monnier K; Cranston DW; Li JL; Harris AL Clin Cancer Res; 2006 Aug; 12(16):4836-44. PubMed ID: 16914569 [TBL] [Abstract][Full Text] [Related]
3. [Influence of Delta-like ligand 4/Notch signal transduction pathway upon the biological behavior of human umbilical vein endothelial cells]. Chen L; Lü W; Wei B; Wang N; Li T Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(44):3106-10. PubMed ID: 20193271 [TBL] [Abstract][Full Text] [Related]
4. Hypoxia-mediated activation of Dll4-Notch-Hey2 signaling in endothelial progenitor cells and adoption of arterial cell fate. Diez H; Fischer A; Winkler A; Hu CJ; Hatzopoulos AK; Breier G; Gessler M Exp Cell Res; 2007 Jan; 313(1):1-9. PubMed ID: 17045587 [TBL] [Abstract][Full Text] [Related]
5. The role of the vascular endothelial growth factor-Delta-like 4 ligand/Notch4-ephrin B2 cascade in tumor vessel remodeling and endothelial cell functions. Hainaud P; Contrerès JO; Villemain A; Liu LX; Plouët J; Tobelem G; Dupuy E Cancer Res; 2006 Sep; 66(17):8501-10. PubMed ID: 16951162 [TBL] [Abstract][Full Text] [Related]
6. Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo. Li JL; Sainson RC; Shi W; Leek R; Harrington LS; Preusser M; Biswas S; Turley H; Heikamp E; Hainfellner JA; Harris AL Cancer Res; 2007 Dec; 67(23):11244-53. PubMed ID: 18056450 [TBL] [Abstract][Full Text] [Related]
7. Cross-talk between leukemic and endothelial cells promotes angiogenesis by VEGF activation of the Notch/Dll4 pathway. Zhang J; Ye J; Ma D; Liu N; Wu H; Yu S; Sun X; Tse W; Ji C Carcinogenesis; 2013 Mar; 34(3):667-77. PubMed ID: 23239744 [TBL] [Abstract][Full Text] [Related]
8. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo. Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174 [TBL] [Abstract][Full Text] [Related]
9. Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis. Caunt M; Hu L; Tang T; Brooks PC; Ibrahim S; Karpatkin S Cancer Res; 2006 Apr; 66(8):4125-32. PubMed ID: 16618733 [TBL] [Abstract][Full Text] [Related]
10. Effect of DLL4 siRNA on proliferation, migration and tube formation of choroid-retinal endothelial cells under hypoxic conditions. He H; Li B; Zhang H; Xiang N; Li GG Chin Med J (Engl); 2011 Jan; 124(1):118-26. PubMed ID: 21362319 [TBL] [Abstract][Full Text] [Related]
12. Plasmalemmal vesicle associated protein-1 is a novel marker implicated in brain tumor angiogenesis. Carson-Walter EB; Hampton J; Shue E; Geynisman DM; Pillai PK; Sathanoori R; Madden SL; Hamilton RL; Walter KA Clin Cancer Res; 2005 Nov; 11(21):7643-50. PubMed ID: 16278383 [TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor and inducible nitric oxide synthase are involved in multidrug resistance-induced angiogenesis in hepatocellular carcinoma cell lines. Lasagna N; Fantappiè O; Solazzo M; Morbidelli L; Marchetti S; Cipriani G; Ziche M; Mazzanti R Cancer Res; 2006 Mar; 66(5):2673-82. PubMed ID: 16510587 [TBL] [Abstract][Full Text] [Related]
14. Regulation of CXCR4 by the Notch ligand delta-like 4 in endothelial cells. Williams CK; Segarra M; Sierra Mde L; Sainson RC; Tosato G; Harris AL Cancer Res; 2008 Mar; 68(6):1889-95. PubMed ID: 18339870 [TBL] [Abstract][Full Text] [Related]
15. Delta-like 4/Notch signaling and its therapeutic implications. Yan M; Plowman GD Clin Cancer Res; 2007 Dec; 13(24):7243-6. PubMed ID: 18094402 [TBL] [Abstract][Full Text] [Related]
16. Nuclear and membrane expression of the angiogenesis regulator delta-like ligand 4 (DLL4) in normal and malignant human tissues. Martinez JC; Müller MM; Turley H; Steers G; Choteau L; Li JL; Sainson R; Harris AL; Pezzella F; Gatter KC Histopathology; 2009 Apr; 54(5):598-606. PubMed ID: 19413639 [TBL] [Abstract][Full Text] [Related]
17. Biological aspects and binding strategies of vascular endothelial growth factor in renal cell carcinoma. Rini BI; Rathmell WK Clin Cancer Res; 2007 Jan; 13(2 Pt 2):741s-746s. PubMed ID: 17255303 [TBL] [Abstract][Full Text] [Related]
18. Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation. Zetser A; Bashenko Y; Edovitsky E; Levy-Adam F; Vlodavsky I; Ilan N Cancer Res; 2006 Feb; 66(3):1455-63. PubMed ID: 16452201 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Ridgway J; Zhang G; Wu Y; Stawicki S; Liang WC; Chanthery Y; Kowalski J; Watts RJ; Callahan C; Kasman I; Singh M; Chien M; Tan C; Hongo JA; de Sauvage F; Plowman G; Yan M Nature; 2006 Dec; 444(7122):1083-7. PubMed ID: 17183323 [TBL] [Abstract][Full Text] [Related]
20. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Noguera-Troise I; Daly C; Papadopoulos NJ; Coetzee S; Boland P; Gale NW; Lin HC; Yancopoulos GD; Thurston G Nature; 2006 Dec; 444(7122):1032-7. PubMed ID: 17183313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]